Lisheng Chu

1.5k total citations · 1 hit paper
43 papers, 1.2k citations indexed

About

Lisheng Chu is a scholar working on Neurology, Molecular Biology and Immunology. According to data from OpenAlex, Lisheng Chu has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Neurology, 15 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Lisheng Chu's work include Neuroinflammation and Neurodegeneration Mechanisms (22 papers), Neurological Disease Mechanisms and Treatments (11 papers) and Immune cells in cancer (7 papers). Lisheng Chu is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (22 papers), Neurological Disease Mechanisms and Treatments (11 papers) and Immune cells in cancer (7 papers). Lisheng Chu collaborates with scholars based in China and United States. Lisheng Chu's co-authors include Yudong Zhou, Guoliang Yu, Xiaowei Hu, San‐Hua Fang, Mengling Wang, Yan Fang, Er-Qing Wei, Lin Li, Yan Yang and Jingjing Gu and has published in prestigious journals such as Scientific Reports, Brain Research and Neuroscience.

In The Last Decade

Lisheng Chu

39 papers receiving 1.1k citations

Hit Papers

Quercetin improves cerebral ischemia/reperfusion injury b... 2023 2026 2024 2025 2023 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Quercetin improves cerebral ischemia/reperfusion injury by promoting microglia/macrophages M2 polarization via regulating PI3K/Akt/NF-κB signaling pathway
    2023 122 citations Lin Li, Weifeng Jiang et al. Biomedicine & Pharmacotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisheng Chu China 19 501 464 170 146 143 43 1.2k
Song‐sheng Shi China 21 497 1.0× 402 0.9× 168 1.0× 111 0.8× 159 1.1× 49 1.3k
Jiayi Zhao China 19 574 1.1× 391 0.8× 170 1.0× 200 1.4× 156 1.1× 44 1.3k
Ruiqin Yao China 22 717 1.4× 310 0.7× 169 1.0× 173 1.2× 232 1.6× 70 1.4k
Ruey‐Horng Shih Taiwan 8 451 0.9× 315 0.7× 179 1.1× 177 1.2× 118 0.8× 9 1.1k
Nobuya Okami United States 13 620 1.2× 666 1.4× 171 1.0× 221 1.5× 105 0.7× 17 1.7k
Juan Ji China 19 576 1.1× 274 0.6× 141 0.8× 144 1.0× 199 1.4× 37 1.2k
Guangxian Nan China 14 366 0.7× 210 0.5× 117 0.7× 105 0.7× 146 1.0× 40 878
Sanaz Nasoohi Iran 19 770 1.5× 318 0.7× 143 0.8× 212 1.5× 66 0.5× 37 1.3k

Countries citing papers authored by Lisheng Chu

Since Specialization
Citations

This map shows the geographic impact of Lisheng Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisheng Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisheng Chu more than expected).

Fields of papers citing papers by Lisheng Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisheng Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisheng Chu. The network helps show where Lisheng Chu may publish in the future.

Co-authorship network of co-authors of Lisheng Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Lisheng Chu. A scholar is included among the top collaborators of Lisheng Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisheng Chu. Lisheng Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Da, et al.. (2025). Research progress on the interaction of artemisinin and its derivatives with TLR4 receptors in neuroinflammation. International Immunopharmacology. 164. 115402–115402.
2.
Zhao, Wenrui, Haimin Zhang, Lin Li, Jianping Zhang, & Lisheng Chu. (2025). Spinosin enhances non-rapid eye movement sleep and alters c-Fos expression in sleep–wake regulatory brain regions in mice. Sleep And Breathing. 29(1). 101–101. 1 indexed citations
3.
Wang, Qianxi, Weifeng Jiang, Yan Feng, et al.. (2025). Therapeutic role of mesenchymal stem cells in neurogenesis for management of neurological disorders: a scientometric study to an in-depth review. Frontiers in Neurology. 16. 1588535–1588535.
4.
Zhang, Weibing, Lei Wang, Lisheng Chu, et al.. (2025). Bivalent circular RNA vaccines against porcine epidemic diarrhea virus and transmissible gastroenteritis virus. Frontiers in Immunology. 16. 1562865–1562865. 2 indexed citations
5.
6.
Zhang, Yani, Yang Zheng, Qian Wang, et al.. (2025). 5-Lipoxygenase triggers depressive-like behaviors via activating NLRP3-induced pyroptosis in CUMS-exposed mice. Neuropharmacology. 282. 110704–110704.
7.
Zhang, Wenqian, et al.. (2025). Investigation of heat and humidity regulation in air-to-air thermoelectric air conditioner with large cooling capacity. Applied Thermal Engineering. 268. 125944–125944. 1 indexed citations
8.
Mao, Shihui, Xiaowei Hu, Li Lin, et al.. (2024). Exosomal miR-486 derived from bone marrow mesenchymal stem cells promotes angiogenesis following cerebral ischemic injury by regulating the PTEN/Akt pathway. Scientific Reports. 14(1). 18086–18086. 13 indexed citations
9.
Wang, Tianyue, et al.. (2023). Exploring the mechanism of luteolin by regulating microglia polarization based on network pharmacology and in vitro experiments. Scientific Reports. 13(1). 13767–13767. 20 indexed citations
10.
Jiang, Weifeng, et al.. (2023). MiR‐199a‐5p enhances neuronal differentiation of neural stem cells and promotes neurogenesis by targeting Cav‐1 after cerebral ischemia. CNS Neuroscience & Therapeutics. 29(12). 3967–3979. 13 indexed citations
11.
Li, Lin, Weifeng Jiang, Baojian Yu, et al.. (2023). Quercetin improves cerebral ischemia/reperfusion injury by promoting microglia/macrophages M2 polarization via regulating PI3K/Akt/NF-κB signaling pathway. Biomedicine & Pharmacotherapy. 168. 115653–115653. 122 indexed citations breakdown →
12.
13.
Cai, Yueqin, Jingan Chen, Jingyan Liu, et al.. (2022). Identification of six hub genes and two key pathways in two rat renal fibrosis models based on bioinformatics and RNA-seq transcriptome analyses. Frontiers in Molecular Biosciences. 9. 1035772–1035772. 7 indexed citations
14.
Lin, Li, Yan Fang, Yan Yang, et al.. (2021). Astragaloside IV promotes microglia/macrophages M2 polarization and enhances neurogenesis and angiogenesis through PPARγ pathway after cerebral ischemia/reperfusion injury in rats. International Immunopharmacology. 92. 107335–107335. 106 indexed citations
15.
16.
Chu, Lisheng, et al.. (2011). Effect of buyanghuanwu decoction on angiogenesis and Ang-1/Tie-2 expression after focal cerebral ischemia in mice. Zhonghua xingwei yixue yu naokexue zazhi. 20(3). 202–204. 2 indexed citations
17.
Chu, Lisheng, San‐Hua Fang, Yudong Zhou, et al.. (2009). Minocycline inhibits 5-lipoxygenase expression and accelerates functional recovery in chronic phase of focal cerebral ischemia in rats. Life Sciences. 86(5-6). 170–177. 35 indexed citations
18.
Zhou, Yudong, Er-Qing Wei, San‐Hua Fang, et al.. (2006). Spatio-temporal properties of 5-lipoxygenase expression and activation in the brain after focal cerebral ischemia in rats. Life Sciences. 79(17). 1645–1656. 62 indexed citations
19.
Zhou, Yudong, San‐Hua Fang, Yilu Ye, et al.. (2006). Caffeic acid ameliorates early and delayed brain injuries after focal cerebral ischemia in rats. Acta Pharmacologica Sinica. 27(9). 1103–1110. 62 indexed citations
20.
Yu, Guoliang, Er-Qing Wei, Mengling Wang, et al.. (2005). Pranlukast, a cysteinyl leukotriene receptor-1 antagonist, protects against chronic ischemic brain injury and inhibits the glial scar formation in mice. Brain Research. 1053(1-2). 116–125. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Song‐sheng Shi Breakdown of academic impact, for papers by Jiayi Zhao Breakdown of academic impact, for papers by Ruiqin Yao Breakdown of academic impact, for papers by Ruey‐Horng Shih Breakdown of academic impact, for papers by Nobuya Okami Breakdown of academic impact, for papers by Juan Ji Breakdown of academic impact, for papers by Guangxian Nan Breakdown of academic impact, for papers by Sanaz Nasoohi
Rankless by CCL
2026